James B Carr, MD
Orthopedic Surgery · San Luis Obispo
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 2
- Since medical school
- 30 years
- Northeastern Ohio University College of Medicine, 1996
Offices
2 locations · David B. Hammer · 117 clinicians in this group
Hospitals listed: 059010 · Adventist Health Sierra Vista · Adventist Health Twin Cities · French Hospital Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Carr’s office at (805) 547-2800 to ask if they take your plan before you enroll.
California Medical Board record
Licence A76013 · Current
Licensed to practise in California · since 2001 · expires 2027-08-31 · Northeastern Ohio Universities College of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Adventist Health Sierra VistaSan Luis Obispo, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 2 of 5 · 57% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.273, Oct 2024 – Sep 2025
- Adventist Health Twin CitiesTempleton, CAAcute Care Hospital · Proprietary · Has an emergency department · Birthing-friendlyPart of Tenet Healthcare, which runs 77 hospitals in 12 statesPatients rate it 3 of 5 · 60% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.41, Oct 2024 – Sep 2025
- French Hospital Medical CenterSan Luis Obispo, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.23, Oct 2024 – Sep 2025
See every measure and the patient survey for Adventist Health Sierra Vista
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 1 better, 5 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.273 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.19 (0.16 to 2.21) · 577 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.54 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 218.26 (161.19 to 275.34) · 33 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.6 · 31 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.6 · 72 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 19.1 · 175 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.5 · 76 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 4 · 874 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.41) · 2,390 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.53) · 2,282 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.97 (0.7 to 5.24) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.38) · 94 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.51 (0.92 to 4.09) · 654 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.57 (0 to 18.3) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.12 (0.83 to 9.41) · 80 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.99 (0.5 to 3.48) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.62 (0 to 1.53) · 2,070 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.7 · 35 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.729 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.63 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.924 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 73 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 67.8 · 79 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7 · 168 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 163 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.7 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.3 (9.2 to 16.6) · 652 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.3 (0.9 to 1.7) · 210 cases | No different | Jan 2024 – Dec 2024 |
What patients said (559 patients answered, 19% of those asked)
| Cleanliness | 2 |
| Nurse communication | 2 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 60% |
| Nurses "always" communicated well | 72% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 66% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 81% |
| Patients who gave a rating of "9" or "10" (high) | 53% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 69% |
| Nurses "always" listened carefully | 67% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 34% |
| "YES", patients would definitely recommend the hospital | 57% |
| Staff "always" explained possible side effects | 43% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for Adventist Health Twin Cities
Behind the star rating — Deaths: 0 better, 5 the same, 0 worse of 5 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.41 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 359 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.94 (0.51 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.2 · 66 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.7 · 198 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.6 · 335 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11.9 · 113 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,156 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.26 (0.03 to 0.48) · 2,873 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.29 (0.08 to 0.5) · 2,701 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.28 (1.85 to 6.72) · 375 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.66 (0 to 3.39) · 38 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.53 (0.84 to 4.22) · 371 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.14 (0 to 19.18) · 39 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.21 (0.88 to 9.54) · 31 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.71 (0.2 to 3.22) · 97 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.32 (0 to 1.28) · 2,369 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 41 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.704 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 257 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 40.3 · 216 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 6.5 · 313 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.5 · 39 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 69 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.4 to 18.7) · 246 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 220 cases | No different | Jan 2024 – Dec 2024 |
What patients said (555 patients answered, 20% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 1 |
| Recommend hospital | 2 |
| Room was "always" clean | 67% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 60% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 73% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 63% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 81% |
| "Always" quiet at night | 35% |
| "YES", patients would definitely recommend the hospital | 60% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for French Hospital Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 5 the same, 0 worse of 6 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.23 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.89 (0 to 1.89) · 660 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.71 (0.39 to 1.04) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 154.33 (99.56 to 209.1) · 63 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 78 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 56 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.3 · 273 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.7 · 355 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 275 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.5 · 69 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 1,569 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 4,085 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.27 (0.07 to 0.47) · 4,358 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.69 (0.53 to 4.85) · 1,221 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.97 (0.47 to 3.48) · 567 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.54 (1.03 to 4.05) · 1,101 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.3 (0.36 to 12.23) · 585 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 3.66 (0.03 to 7.29) · 576 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.98 (0.5 to 3.47) · 185 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.2 (0 to 0.96) · 3,231 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.2 · 53 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 2.935 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.6 · 252 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.5 · 330 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2.9 · 296 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -8.5 · 382 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 2 · 272 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.9 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.1 (3.2 to 8) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.5 to 14.1) · 25 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.5 · 40 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10 · 77 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.7 (8.9 to 15.1) · 837 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 706 cases | No different | Jan 2024 – Dec 2024 |
What patients said (706 patients answered, 28% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 1 |
| Recommend hospital | 5 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 72% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 33% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 48% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$111,675
Medicare paid this office $111,675 for 376 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 173 | $26,202 | $101 |
| New patient visit (60+ min) | 146 | $24,597 | $168 |
| Short return visit (20+ min) | 177 | $20,134 | $68 |
| New patient visit (45+ min) | 40 | $4,591 | $115 |
| Aspiration and/or injection of fluid from large joint | 29 | $1,959 | $49 |
See all 9 services
| Return visit (30+ min) | 173 | $26,202 | $101 |
| New patient visit (60+ min) | 146 | $24,597 | $168 |
| Short return visit (20+ min) | 177 | $20,134 | $68 |
| New patient visit (45+ min) | 40 | $4,591 | $115 |
| Aspiration and/or injection of fluid from large joint | 29 | $1,959 | $49 |
| Long return visit (40+ min) | 16 | $1,798 | $106 |
| New patient visit (30+ min) | 16 | $1,224 | $77 |
| X-ray of spine, 1 view | 26 | $314 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 21 | $95 | None |
Procedures Medicare counted
| Laminectomy or laminotomy (partial removal of spine bones) | 23 | More than 53% of doctors who do this |
| Spinal fusion | 30 | More than 44% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Aspiration and/or injection of fluid from large joint | 33 | 39 | 60 | 67 | 78 | 40 |
| Placement of device to stabilize or reduce pressure in lower spine in 1 disc space | 27 | 26 | 31 | 30 | 18 | – |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 11 | – | – | – | 13 | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
376 Original Medicare patients in 2024. Average age 74 · Under 65 5% · 85 and older 6% · Women 55% · Also on Medicaid 9% · Health risk score 0.87. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 67% · Coronary heart disease 23% · Depression 18% · Diabetes 16% · Chronic kidney disease 13% · Atrial fibrillation 13% · Cancer 12% · COPD 11% · Heart failure 7% · Stroke 3%.
The office billed $453,933, Medicare allowed $150,065 and paid $111,675; for 944 services of 26 kinds; $95 of it was for drugs given in the office and $111,580 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 376 | 944 | 74 | 0.87 | $453,933 | $111,675 |
| 2023 | 406 | 1,175 | 73 | 0.88 | $531,738 | $129,858 |
| 2022 | 455 | 1,328 | 73 | 0.85 | $627,308 | $148,736 |
| 2021 | 562 | 1,528 | 72 | 0.88 | $612,612 | $161,889 |
| 2020 | 348 | 902 | 73 | 0.97 | $296,455 | $93,950 |
| 2019 | 459 | 1,184 | 73 | 0.94 | $512,000 | $141,195 |
| 2018 | 506 | 1,344 | 73 | 1.07 | $716,335 | $169,947 |
| 2017 | 502 | 1,315 | 73 | 1.00 | $540,771 | $146,199 |
| 2016 | 534 | 1,442 | 72 | 0.84 | $644,515 | $174,889 |
| 2015 | 481 | 1,438 | 72 | 0.94 | $546,222 | $166,329 |
| 2014 | 499 | 1,316 | 72 | 0.98 | $516,909 | $140,511 |
| 2013 | 386 | 1,169 | 71 | 0.87 | $530,878 | $126,229 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 10 services
| Return visit (30+ min) | 209 | $31,608 | $100 |
| Short return visit (20+ min) | 195 | $21,933 | $68 |
| New patient visit (60+ min) | 120 | $20,710 | $173 |
| Placement of device to stabilize or reduce pressure in lower spine in 1 disc space | 18 | $15,206 | $845 |
| New patient visit (45+ min) | 75 | $9,557 | $127 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 13 | $9,496 | $730 |
| Aspiration and/or injection of fluid from large joint | 59 | $4,109 | $53 |
| New patient visit (30+ min) | 25 | $1,936 | $77 |
| Injection, methylprednisolone acetate, 40 mg | 63 | $603 | None |
| X-ray of spine, 1 view | 41 | $463 | $6 |
2022: 12 services
| Return visit (30+ min) | 210 | $32,641 | $97 |
| Placement of device to stabilize or reduce pressure in lower spine in 1 disc space | 30 | $25,178 | $839 |
| New patient visit (60+ min) | 140 | $22,580 | $161 |
| Short return visit (20+ min) | 178 | $19,455 | $72 |
| New patient visit (45+ min) | 79 | $9,944 | $126 |
| Aspiration and/or injection of fluid from large joint | 55 | $3,313 | $49 |
| New patient visit (30+ min) | 31 | $2,584 | $83 |
| Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | 26 | $1,859 | $41 |
| Long return visit (40+ min) | 13 | $1,805 | $139 |
| Injection, methylprednisolone acetate, 40 mg | 60 | $692 | None |
| X-ray of spine, 1 view | 45 | $531 | $6 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 13 | $426 | $25 |
2021: 15 services
| Return visit (30+ min) | 231 | $44,217 | $103 |
| New patient visit (60+ min) | 169 | $29,656 | $175 |
| Placement of device to stabilize or reduce pressure in lower spine in 1 disc space | 31 | $24,906 | $803 |
| New patient visit (45+ min) | 81 | $10,033 | $124 |
| Short return visit (20+ min) | 79 | $6,809 | $72 |
| New patient visit (15+ min) | 58 | $3,971 | $68 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 47 | $3,825 | $75 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within | 119 | $3,200 | $25 |
| Aspiration and/or injection of fluid from large joint | 45 | $3,180 | $53 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 91 | $2,274 | $24 |
| Long return visit (40+ min) | 12 | $1,743 | $145 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 36 | $1,560 | $43 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $872 | $51 |
| X-ray of spine, 1 view | 44 | $663 | $7 |
| Injection, methylprednisolone acetate, 40 mg | 50 | $469 | None |
2020: 8 services
| New patient visit (60+ min) | 150 | $23,026 | $154 |
| Return visit (30+ min) | 178 | $19,714 | $72 |
| Placement of device to stabilize or reduce pressure in lower spine in 1 disc space | 26 | $18,650 | $717 |
| Short return visit (20+ min) | 107 | $9,460 | $58 |
| New patient visit (45+ min) | 51 | $5,723 | $112 |
| Aspiration and/or injection of fluid from large joint | 29 | $1,868 | $48 |
| X-ray of spine, 1 view | 33 | $499 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 29 | $340 | None |
2019: 9 services
| Return visit (30+ min) | 284 | $40,863 | $77 |
| New patient visit (60+ min) | 223 | $33,448 | $150 |
| Placement of device to stabilize or reduce pressure in lower spine in 1 disc space | 27 | $19,870 | $736 |
| New patient visit (45+ min) | 70 | $8,898 | $127 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 11 | $8,231 | $748 |
| Short return visit (20+ min) | 23 | $1,704 | $57 |
| Aspiration and/or injection of fluid from large joint | 22 | $1,534 | $46 |
| X-ray of spine, 1 view | 51 | $722 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 28 | $410 | None |
2018: 10 services
| Return visit (30+ min) | 341 | $53,983 | $77 |
| New patient visit (60+ min) | 281 | $41,912 | $149 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 21 | $15,002 | $714 |
| Fusion of spine in lower back | 12 | $14,224 | $1,185 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 20 | $13,628 | $681 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 16 | $2,991 | $157 |
| New patient visit (45+ min) | 29 | $2,932 | $101 |
| Aspiration and/or injection of fluid from large joint | 16 | $952 | $43 |
| X-ray of spine, 1 view | 49 | $635 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 24 | $329 | None |
2017: 13 services
| Return visit (30+ min) | 310 | $39,797 | $74 |
| New patient visit (60+ min) | 206 | $29,858 | $145 |
| Fusion of spine in lower back | 11 | $13,113 | $1,192 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 16 | $10,987 | $687 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 16 | $10,335 | $646 |
| New patient visit (45+ min) | 85 | $8,838 | $104 |
| Placement of stabilizing device to back of 1 spine bone in neck | 11 | $6,229 | $566 |
| Short return visit (20+ min) | 42 | $2,834 | $51 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 13 | $2,200 | $157 |
| Aspiration and/or injection of fluid from large joint | 36 | $2,058 | $39 |
| Injection, methylprednisolone acetate, 40 mg | 53 | $703 | None |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 14 | $621 | $41 |
| X-ray of spine, 1 view | 36 | $441 | $6 |
2016: 11 services
| Return visit (30+ min) | 298 | $40,821 | $77 |
| New patient visit (60+ min) | 249 | $39,214 | $157 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 24 | $18,065 | $753 |
| New patient visit (45+ min) | 95 | $11,520 | $121 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 17 | $11,346 | $667 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 18 | $2,945 | $164 |
| Short return visit (20+ min) | 37 | $2,689 | $53 |
| Aspiration and/or injection of fluid from large joint | 48 | $2,523 | $46 |
| Long return visit (40+ min) | 17 | $1,777 | $105 |
| X-ray of spine, 1 view | 51 | $809 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 62 | $671 | None |
2015: 9 services
| Return visit (30+ min) | 261 | $43,505 | $85 |
| New patient visit (60+ min) | 195 | $31,768 | $163 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 27 | $22,139 | $820 |
| New patient visit (45+ min) | 114 | $13,596 | $119 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 16 | $12,850 | $803 |
| Short return visit (20+ min) | 94 | $6,142 | $52 |
| Aspiration and/or injection of fluid from large joint | 44 | $3,004 | $50 |
| X-ray of spine, 1 view | 47 | $625 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 64 | $583 | None |
2014: 15 services
| Return visit (30+ min) | 251 | $34,901 | $81 |
| New patient visit (60+ min) | 134 | $21,096 | $157 |
| New patient visit (45+ min) | 161 | $20,048 | $125 |
| Partial removal of spine bone with release of lower spinal cord or nerves and/or removal of disc | 19 | $14,618 | $769 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 13 | $10,357 | $797 |
| Short return visit (20+ min) | 124 | $8,605 | $54 |
| New patient visit (30+ min) | 27 | $2,236 | $83 |
| Aspiration and/or injection of fluid from large joint | 34 | $1,839 | $45 |
| Injection of trigger points, 1-2 muscles | 13 | $713 | $42 |
| X-ray lower and sacral spine, 2-3 views bending views | 19 | $675 | $34 |
| X-ray of spine, 1 view | 39 | $490 | $6 |
| Psychological testing with interpretation and report by computer | 19 | $397 | $21 |
| X-ray of spine, 1 view | 19 | $384 | $19 |
| X-ray of lower and sacral spine, 2-3 views | 12 | $359 | $28 |
| Injection, methylprednisolone acetate, 40 mg | 52 | $201 | None |
2013: 14 services
| Return visit (30+ min) | 219 | $29,526 | $80 |
| Partial removal of spine bone with release of lower spinal cord and/or nerves, 1 segment | 23 | $16,628 | $723 |
| New patient visit (60+ min) | 103 | $15,827 | $154 |
| New patient visit (45+ min) | 108 | $13,317 | $123 |
| Short return visit (20+ min) | 78 | $5,364 | $55 |
| Partial removal of spine bone with release of spinal cord and/or nerves, each additional segment | 15 | $2,255 | $150 |
| X-ray lower and sacral spine, 2-3 views bending views | 44 | $1,585 | $36 |
| New patient visit (30+ min) | 19 | $1,555 | $82 |
| Aspiration and/or injection of fluid from large joint | 28 | $1,508 | $47 |
| X-ray of lower and sacral spine, 2-3 views | 31 | $1,320 | $30 |
| X-ray of spine, 1 view | 45 | $893 | $20 |
| X-ray of upper spine, 2-3 views | 24 | $811 | $28 |
| X-ray of spine, 1 view | 35 | $414 | $6 |
| Injection, methylprednisolone acetate, 40 mg | 40 | $128 | None |
Medicaid work
$1,524 in 2023
Medicaid paid $1,524 for 13 billed services this clinician did in 2023, up to 12 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 13 | $1,524 |
| 2023 | 13 | 1 | 12 | $1,524 |
| 2022 | 32 | 2 | 18 | $1,060 |
| 2021 | 1,007 | 8 | 83 | $42,516 |
| 2018 | 30 | 1 | 14 | $2,668 |
See the largest Medicaid services in earlier years
2022
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 18 | $621 |
| OFF/OP EST MAY X REQ PHY/QHP | 14 | $439 |
2021
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 118 | $8,250 |
| OFF/OP EST MAY X REQ PHY/QHP | 208 | $6,963 |
| Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 267 | $6,053 |
| OFFICE/OUTPATIENT NEW SF MDM 15 MINUTES | 55 | $5,239 |
| Infectious agent antigen detection by immunoassay with direct optical (ie, visual) observation; severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]) | 119 | $4,666 |
| Infectious agent detection by nucleic acid (DNA or RNA); severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease [COVID-19]), amplified probe technique | 92 | $4,459 |
| Return visit (30+ min) | 26 | $4,162 |
| Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 122 | $2,725 |
2018
| Return visit (30+ min) | 30 | $2,668 |
Drugs they prescribed that Part D paid
$3,753
Pharmacies billed $3,753 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 41% of their Part D prescriptions (188 of 461) in 2024. Above the middle of the specialty; the typical orthopedic surgery clinician is at 31%. Surgeons prescribe little besides pain medicine after an operation, so their opioid share runs high.
459 generic and fewer than 11 brand-name prescriptions · $3,753 in drug cost · 11 antibiotic prescriptions.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Hydrocodone-Acetaminophen | 126 | $1,172 | $9 |
| Gabapentin | 91 | $639 | $7 |
| Carisoprodol | 18 | $396 | $22 |
| Ibuprofen | 51 | $340 | $7 |
| Oxycodone-Acetaminophen | 22 | $186 | $8 |
See all 9 drugs
| Hydrocodone-Acetaminophen | 126 | $1,172 | $9 |
| Gabapentin | 91 | $639 | $7 |
| Carisoprodol | 18 | $396 | $22 |
| Ibuprofen | 51 | $340 | $7 |
| Oxycodone-Acetaminophen | 22 | $186 | $8 |
| Tramadol | 30 | $182 | $6 |
| Methylprednisolone | 16 | $100 | $6 |
| Meloxicam | 29 | $63 | $2 |
| Cyclobenzaprine | 11 | $19 | $2 |
Year by year
| 2024 | 461 | 129 | 41% (188) | None | $3,753 |
| 2023 | 607 | 149 | 43% (259) | 0% | $5,576 |
| 2022 | 416 | 126 | 45% (187) | None | $3,806 |
| 2021 | 333 | 99 | 38% (125) | None | $3,983 |
| 2020 | 271 | 92 | 38% (103) | None | $3,381 |
| 2019 | 339 | 105 | 39% (132) | None | $6,914 |
| 2018 | 487 | 121 | 53% (257) | None | $11,884 |
| 2017 | 470 | 122 | 64% (300) | None | $10,906 |
| 2016 | 517 | 116 | 57% (297) | 2% | $16,035 |
| 2015 | 496 | 107 | 59% (291) | 4% | $16,681 |
| 2014 | 491 | 99 | 71% (350) | 5% | $20,156 |
| 2013 | 487 | 95 | 60% (294) | 9% | $17,717 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Hydrocodone-Acetaminophen | 129 | $1,371 | $11 |
| Ibuprofen | 89 | $656 | $7 |
| Acetaminophen-Codeine | 16 | $617 | $39 |
| Oxycodone-Acetaminophen | 66 | $536 | $8 |
| Gabapentin | 55 | $363 | $7 |
| Meloxicam | 60 | $297 | $5 |
| Diclofenac | 13 | $209 | $16 |
| Tramadol | 27 | $205 | $8 |
| Oxycodone | 21 | $199 | $9 |
| Methocarbamol | 11 | $110 | $10 |
| Diazepam | 21 | $110 | $5 |
| Naproxen | 24 | $72 | $3 |
| Alprazolam | 11 | $17 | $2 |
2022: 12 drugs
| Hydrocodone-Acetaminophen | 92 | $1,151 | $13 |
| Oxycodone-Acetaminophen | 43 | $613 | $14 |
| Ibuprofen | 67 | $403 | $6 |
| Acetaminophen-Codeine | 12 | $359 | $30 |
| Gabapentin | 35 | $164 | $5 |
| Tramadol | 24 | $144 | $6 |
| Oxycodone | 16 | $103 | $6 |
| Methocarbamol | 12 | $57 | $5 |
| Meloxicam | 18 | $48 | $3 |
| Azithromycin | 14 | $43 | $3 |
| Diazepam | 26 | $43 | $2 |
| Alprazolam | 11 | $12 | $1 |
2021: 8 drugs
| Oxycodone-Acetaminophen | 30 | $627 | $21 |
| Ibuprofen | 88 | $610 | $7 |
| Hydrocodone-Acetaminophen | 60 | $482 | $8 |
| Acetaminophen-Codeine | 13 | $328 | $25 |
| Gabapentin | 27 | $153 | $6 |
| Oxycodone | 14 | $74 | $5 |
| Meloxicam | 12 | $37 | $3 |
| Diazepam | 17 | $34 | $2 |
2020: 6 drugs
| Oxycodone-Acetaminophen | 17 | $669 | $39 |
| Hydrocodone-Acetaminophen | 58 | $400 | $7 |
| Ibuprofen | 60 | $323 | $5 |
| Gabapentin | 36 | $304 | $8 |
| Diazepam | 22 | $105 | $5 |
| Tramadol | 16 | $74 | $5 |
2019: 9 drugs
| Hydrocodone-Acetaminophen | 67 | $1,232 | $18 |
| Acetaminophen-Codeine | 22 | $941 | $43 |
| Oxycodone | 17 | $390 | $23 |
| Gabapentin | 30 | $305 | $10 |
| Ibuprofen | 46 | $301 | $7 |
| Ibu | 18 | $133 | $7 |
| Diazepam | 19 | $76 | $4 |
| Alprazolam | 11 | $68 | $6 |
| Tramadol | 16 | $44 | $3 |
2018: 11 drugs
| Hydrocodone-Acetaminophen | 132 | $3,426 | $26 |
| Acetaminophen-Codeine | 35 | $2,561 | $73 |
| Oxycodone-Acetaminophen | 41 | $1,189 | $29 |
| Oxycodone | 25 | $466 | $19 |
| Gabapentin | 37 | $419 | $11 |
| Ibu | 42 | $212 | $5 |
| Ibuprofen | 41 | $177 | $4 |
| Diclofenac | 14 | $140 | $10 |
| Tramadol | 24 | $113 | $5 |
| Carisoprodol | 14 | $92 | $7 |
| Diazepam | 14 | $17 | $1 |
2017: 12 drugs
| Hydrocodone-Acetaminophen | 160 | $3,677 | $23 |
| Oxycodone-Acetaminophen | 57 | $2,191 | $38 |
| Acetaminophen-Codeine | 21 | $849 | $40 |
| Oxycodone | 32 | $548 | $17 |
| Gabapentin | 25 | $400 | $16 |
| Diclofenac | 16 | $196 | $12 |
| Ibuprofen | 26 | $122 | $5 |
| Tramadol | 22 | $115 | $5 |
| Carisoprodol | 15 | $72 | $5 |
| Ibu | 15 | $48 | $3 |
| Diazepam | 22 | $36 | $2 |
| Alprazolam | 13 | $27 | $2 |
2016: 9 drugs
| Hydrocodone-Acetaminophen | 149 | $4,889 | $33 |
| Celecoxib | 22 | $4,347 | $198 |
| Oxycodone-Acetaminophen | 54 | $2,305 | $43 |
| Acetaminophen-Codeine | 23 | $801 | $35 |
| Gabapentin | 40 | $582 | $15 |
| Ibuprofen | 82 | $489 | $6 |
| Oxycodone | 17 | $391 | $23 |
| Diclofenac | 17 | $331 | $19 |
| Tramadol | 41 | $245 | $6 |
2015: 9 drugs
| Hydrocodone-Acetaminophen | 185 | $6,535 | $35 |
| Oxycodone-Acetaminophen | 17 | $832 | $49 |
| Acetaminophen-Codeine | 23 | $757 | $33 |
| Ibuprofen | 67 | $442 | $7 |
| Gabapentin | 26 | $370 | $14 |
| Diclofenac | 22 | $319 | $15 |
| Oxycodone | 13 | $274 | $21 |
| Tramadol | 40 | $220 | $5 |
| Lorazepam | 21 | $53 | $3 |
2014: 7 drugs
| Hydrocodone-Acetaminophen | 224 | $4,365 | $19 |
| Acetaminophen-Codeine | 55 | $1,043 | $19 |
| Diclofenac | 22 | $440 | $20 |
| Tramadol | 58 | $382 | $7 |
| Gabapentin | 16 | $369 | $23 |
| Ibuprofen | 25 | $162 | $6 |
| Alprazolam | 13 | $84 | $6 |
2013: 9 drugs
| Hydrocodone-Acetaminophen | 187 | $2,475 | $13 |
| Diclofenac Sodium-Misoprostol | 12 | $2,057 | $171 |
| Acetaminophen-Codeine | 65 | $1,521 | $23 |
| Gabapentin | 19 | $443 | $23 |
| Tramadol | 33 | $414 | $13 |
| Diclofenac | 17 | $392 | $23 |
| Alprazolam | 44 | $284 | $6 |
| Ibuprofen | 18 | $106 | $6 |
| Carisoprodol | 15 | $102 | $7 |
Money from drug and device companies
$345 in 2025
| 2025 | 4 | 6 | None | $345 |
| 2024 | 4 | 8 | None | $713 |
| 2023 | 6 | 24 | None | $2,596 |
| 2022 | 4 | 28 | None | $2,566 |
| 2021 | 5 | 18 | $769 | $2,358 |
| 2020 | 5 | 30 | None | $2,834 |
| 2019 | 6 | 24 | None | $9,761 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Carlsmed | Aprevo | $115 | 1 payment
|
| Globus Medical | Simplify Cervical Artificial Disc | $88 | 2 payments
|
| Xtant Medical | None | $79 | 2 payments
|
| Biotissue Holdings | None | $63 | 1 payment
|
See all 6 published payments
| Carlsmed | Meals · 2025-11-18 | Aprevo | $115 |
| Xtant Medical | Meals · 2025-10-09 | None | $49 |
| Globus Medical | Meals · 2025-08-13 | Simplify Cervical Artificial Disc | $42 |
| Globus Medical | Meals · 2025-04-10 | Simplify Cervical Artificial Disc | $46 |
| Xtant Medical | Meals · 2025-04-03 | None | $30 |
| Biotissue Holdings | Meals · 2025-03-11 | None | $63 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $713
| Medtronic | Anteralign Spinal System With Titan Nanolock Surface Technology | $328 | 3 payments
|
| Xtant Medical | None | $267 | 3 payments
|
| Providence Medical Technology | None | $96 | 1 payment
|
| Cornerstone Medical Associates | None | $23 | 1 payment
|
2023: $2,596
| Medtronic | Mazor X System | $2,124 | 16 payments
|
| Xtant Medical | None | $285 | 4 payments
|
| Providence Medical Technology | None | $60 | 1 payment
|
| Centinel Spine | Prodisc C Vivo | $57 | 1 payment
|
| Zavation Medical Products | None | $45 | 1 payment
|
| Innovasis | None | $25 | 1 payment
|
2022: $2,566
| Medtronic | Pivox Oblique Lateral Spinal System | $1,211 | 12 payments
|
| Surgalign Spine Technologies | Coflex Interlaminar Technology, 10mm | $823 | 9 payments
|
| CoreLink | None | $383 | 5 payments
|
| Cerapedics | I-Factor Peptide Enhanced Bone Graft | $149 | 2 payments
|
2021: $2,358
| Surgalign Spine Technologies | Coflex Interlaminar Technology, 10mm | $1,070 | 5 payments
|
| CoreLink | None | $471 | 4 payments
|
| Sanara MedTech | Celleraterx | $457 | 3 payments
|
| Medtronic | Unid | $294 | 5 payments
|
| Smith+Nephew | Lens 4k | $66 | 1 payment
|
2020: $2,834
| Medtronic USA | Pivox Oblique Lateral Spinal System | $2,291 | 22 payments
|
| Surgalign Spine Technologies | Coflex | $405 | 5 payments
|
| CoreLink | None | $97 | 1 payment
|
| Pacira Pharmaceuticals | Exparel | $22 | 1 payment
|
| Zimmer Biomet Holdings | Biomet Spinalpak | $20 | 1 payment
|
2019: $9,761
| Smith+Nephew | None | $8,000 | 1 payment
|
| Medtronic USA | Pivox Oblique Lateral Spinal System | $1,219 | 15 payments
|
| RTI Surgical | Allograft | $414 | 5 payments
|
| Paradigm Spine | Coflex | $64 | 1 payment
|
| Alphatec Spine | Lif | $44 | 1 payment
|
| Bioventus | Durolane | $20 | 1 payment
|
Checkups this office reported
9 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 75.3 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 0%That's few of the people this applied to. | 611 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 0%That's few of the people this applied to. | 23 |
| Checked for fall riskOlder patients screened for fall risk | 0%That's few of the people this applied to. | 545 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 45% | 642 |
| Depression screeningPatients screened for depression, with a follow-up plan if needed | 0%That's few of the people this applied to. | 1,062 |
| Medications listed in the chartVisits where the current medication list was documented | 80%That's most of the people this applied to. | 2,177 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 3%That's few of the people this applied to. Better on this measure. | 562 |
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 0% | 1,631 |
See the other 1 measures
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 23%That's few of the people this applied to. | 1,010 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- Uses standard treatment protocols
Professional record
- NPI
- 1720197353
- Licence
- CA A76013California A76013: Current · expires 2027-08-31
- Trained
- Northeastern Ohio University College of Medicine, 1996 · 30 years ago
- Group
- David B. Hammer
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 207XS0117X (207XS0117X)
- Mailing address
- 8844 Morro Rd, Atascadero, CA, 93422
- NPI first listed
- 2006-08-29
- NPI last updated
- 2022-10-10
- NPI record certified
- 2022-10-10
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 8844 Morro Rd, Atascadero, CA, 93422